semaglutide ema approval Semaglutide: First Global | Drugs EMA 2025: 38 Novel Drugs

Side effects of creatine may include dehydration, diarrhea, and nausea

Frias JP, Nauck MA, Van J et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial

Eliminating or cutting down on blood pressure drugs can translate into six hundred to one thousand eight hundred dollars saved annually

However, we recommend consulting with your physician for the right dose and use

They are intended for adults with type 2 diabetes (or, for weight management, the approved brands Wegovy or Zepbound)

If dietary restrictions (vegetarian, vegan, food allergies) make hitting 80-100g protein daily impossible, a less aggressive approach may be more appropriate